Literature DB >> 3099557

The effect of anti-rheumatic drugs on factors from porcine synovium inducing chondrocyte mediated cartilage degradation.

K G Couchman, H Sheppeard.   

Abstract

A selection of NSAID's and diphosphonates were studied in a tissue culture model of cartilage degradation utilising porcine synovium and bovine nasal cartilage. All the NSAID's significantly reduced cartilage degradation when incorporated into the synovial culture medium. Lesser reductions were recorded when preformed chondrocyte stimulating factors were used and NSAID's added at the cartilage assay stage. These findings suggested that the principle site of action of NSAID's is upon the production of chondrocyte stimulating factors. None of the NSAID's tested affected inherent cartilage degradation. Diphosphonates had the opposite effects, they increased inherent cartilage degradation but had no effect on chondrocyte mediated cartilage degradation. The relationship of these results to previous known effects of NSAID's and diphosphonates upon cartilage is discussed. In addition, correlations between chondrocyte stimulating factors, catabolin and interleukin 1 are made.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3099557     DOI: 10.1007/bf01977266

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  23 in total

1.  Cardiac catabolic factors: the degradation of heart valve intercellular matrix.

Authors:  R S Decker; J T Dingle
Journal:  Science       Date:  1982-02-19       Impact factor: 47.728

2.  Salicylate inhibition of cartilage degeneration.

Authors:  D P Simmons; O D Chrisman
Journal:  Arthritis Rheum       Date:  1965-10

3.  A tissue culture model of cartilage breakdown in rheumatoid arthritis. III. Effects of antirheumatic drugs.

Authors:  J Steinberg; S Tsukamoto; C B Sledge
Journal:  Arthritis Rheum       Date:  1979-08

4.  Human mononuclear cell factors mediate cartilage matrix degradation through chondrocyte activation.

Authors:  H E Jasin; J T Dingle
Journal:  J Clin Invest       Date:  1981-09       Impact factor: 14.808

5.  Pig catabolin is a form of interleukin 1. Cartilage and bone resorb, fibroblasts make prostaglandin and collagenase, and thymocyte proliferation is augmented in response to one protein.

Authors:  J Saklatvala; L M Pilsworth; S J Sarsfield; J Gavrilovic; J K Heath
Journal:  Biochem J       Date:  1984-12-01       Impact factor: 3.857

6.  Effects of antirheumatoid drugs on the production and action of porcine catabolin.

Authors:  H Sheppeard; L M Pilsworth; B Hazleman; J T Dingle
Journal:  Ann Rheum Dis       Date:  1982-10       Impact factor: 19.103

7.  Catabolin--a cartilage catabolic factor from synovium.

Authors:  J T Dingle
Journal:  Clin Orthop Relat Res       Date:  1981-05       Impact factor: 4.176

8.  Characterization of catabolin, the major product of pig synovial tissue that induces resorption of cartilage proteoglycan in vitro.

Authors:  J Saklatvala
Journal:  Biochem J       Date:  1981-12-01       Impact factor: 3.857

9.  A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures.

Authors:  R W Farndale; C A Sayers; A J Barrett
Journal:  Connect Tissue Res       Date:  1982       Impact factor: 3.417

10.  Destruction of articular cartilage by arthritic synovium in vitro: mechanism of breakdown and effect of indomethacin and prednisolone.

Authors:  J Panagides; M J Landes; A E Sloboda
Journal:  Agents Actions       Date:  1980-04
View more
  3 in total

Review 1.  A comparison of synovial fluid concentrations of non-steroidal anti-inflammatory drugs with their in vitro activity.

Authors:  E Urquhart
Journal:  Agents Actions       Date:  1991-03

Review 2.  What's happened to catabolin?

Authors:  H Sheppeard; K G Couchman
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

3.  Effects of NSAIDs on the metabolism of sulphated glycosaminoglycans in healthy and (post) arthritic murine articular cartilage.

Authors:  B J de Vries; W B van den Berg; E Vitters; L B van de Putte
Journal:  Drugs       Date:  1988       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.